CYCLERION THERAPEUTICS, INC.: operating income or loss
Operating income or loss for CYCLERION THERAPEUTICS, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All CYCLERION THERAPEUTICS, INC. financial histories
What this measure means
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
Exact concept: us-gaap:OperatingIncomeLoss. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2018-01-01 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | -4,973,000 | USD | 2026-03-30 | 10-K · 0001193125-26-132193 |
| 2024-01-01 | 2024-12-31 | -3,628,000 | USD | 2026-03-30 | 10-K · 0001193125-26-132193 |
| 2023-01-01 | 2023-12-31 | -12,951,000 | USD | 2025-11-12 | 10-K/A · 0001193125-25-277621 |
| 2022-01-01 | 2022-12-31 | -18,540,000 | USD | 2024-03-05 | 10-K · 0000950170-24-025935 |
| 2021-01-01 | 2021-12-31 | -55,195,000 | USD | 2023-03-22 | 10-K · 0000950170-23-009223 |
| 2020-01-01 | 2020-12-31 | -81,265,000 | USD | 2022-02-24 | 10-K · 0000950170-22-001958 |
| 2019-01-01 | 2019-12-31 | -125,037,000 | USD | 2021-02-25 | 10-K · 0001564590-21-008434 |
| 2018-01-01 | 2018-12-31 | -115,252,000 | USD | 2020-03-12 | 10-K · 0001104659-20-032554 |
Related financial histories
- CYCLERION THERAPEUTICS, INC.: total assets
- CYCLERION THERAPEUTICS, INC.: stockholders equity
- CYCLERION THERAPEUTICS, INC.: cash and cash equivalents
- CYCLERION THERAPEUTICS, INC.: net income or loss
- CYCLERION THERAPEUTICS, INC.: operating cash flow
- CYCLERION THERAPEUTICS, INC.: capital expenditure payments
- CYCLERION THERAPEUTICS, INC.: revenue
- CYCLERION THERAPEUTICS, INC.: financing cash flow
- CYCLERION THERAPEUTICS, INC.: investing cash flow
- CYCLERION THERAPEUTICS, INC.: retained earnings or deficit
- CYCLERION THERAPEUTICS, INC.: basic weighted-average shares
- CYCLERION THERAPEUTICS, INC.: diluted weighted-average shares
- CYCLERION THERAPEUTICS, INC.: basic earnings per share
- CYCLERION THERAPEUTICS, INC.: diluted earnings per share
- CYCLERION THERAPEUTICS, INC.: net property, plant and equipment
- CYCLERION THERAPEUTICS, INC.: share-based compensation expense
- CYCLERION THERAPEUTICS, INC.: current assets
- CYCLERION THERAPEUTICS, INC.: current liabilities
- CYCLERION THERAPEUTICS, INC.: current accounts payable
- CYCLERION THERAPEUTICS, INC.: net current accounts receivable
- CYCLERION THERAPEUTICS, INC.: operating expenses
- CYCLERION THERAPEUTICS, INC.: research and development expense
Inspect the source
- Entity
- CYCLERION THERAPEUTICS, INC. / CIK 0001755237
- Captured
- 2026-09-21T17:26:11.082Z
- SEC response SHA-256
abd561465c7c58e7a74a3b7dba64bfbb0f341a31d46981d969e542933a71056c
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001755237.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))